Myriad Genetics (NASDAQ:MYGN) Rating Lowered to “Hold” at StockNews.com
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities research analysts have also recently commented on the stock. Piper Sandler reduced their price target on shares of Myriad […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities research analysts have also recently commented on the stock. Piper Sandler reduced their price target on shares of Myriad […]
